| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |